Fig. 3From: Prediction of the Ki-67 marker index in hepatocellular carcinoma based on Dynamic Contrast-Enhanced Ultrasonography with SonazoidDynamic contrast-enhanced ultrasound perfusion analysis using the NovoUltrasound Kit (NUK, version 1.5.0, GE Healthcare Shanghai) of histopathological proven hepatocellular carcinoma. 3a PE in the Kupffer phase of high Ki-67 expression group; 3b PE in the Kupffer phase of low Ki-67 expression group; 3c MRI T2 image of 3a; 3d The CT arterial phase of 3bBack to article page